Describe for the first time the antitumor activity of RAS inhibitors in preclinical models of cholangiocarcinoma
The authors also identified therapeutic combinations with the potential to improve outcomes in cholangiocarcinoma PAMPLONA, SPAIN, April 24, 2026 /EINPresswire.com/ -- Researchers from Cima University of Navarra, in collaboration with Revolution …